Dr. Rozencweig is a medical oncologist with more than 40 years of experience in clinical trials and anti-cancer drug development at the National Cancer Institute and in the pharmaceutical industry. Dr. Rozencweig has served in various global drug development leadership positions at Bristol-Myers Squibb in worldwide clinical R&D, strategic marketing, portfolio management, and portfolio development. He built and led the BMS clinical research group that developed all NCE’s brought to market in the field of cancer from 1983 to 2001. Dr. Rozencweig has held senior management positions at several small US and international biotechnology companies.